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Abstract: Because the effects of age, menopausal status, weight and body mass index (BMI) on
ovarian detectability by transvaginal ultrasound (TVS) have not been established, we determined
their contributions to TVS visualization of the ovaries when one or both ovaries are visualized on
the first ultrasound exam. A total of 29,877 women that had both ovaries visualized on their first
exam were followed over 202,639 prospective TVS exams and 9703 women that had only one ovary
visualized on their first exam were followed over 63,702 ultrasonography exams. All images were
reviewed by a physician. While non-visualization of both ovaries increased with age in women
selected on the basis of the visualization of only one ovary on their first ultrasound exam, one or both
ovaries could be visualized in two out of every three women at 80 years of age and more than 50% of
women over 80 years of age. At each age, more non-visualizations were associated with women that
had only one ovary visualized on their first visit. Having only one ovary visualized on the first exam
advanced non-visualizations by an average of ~10 years across all ages and by >20 years in women
under 40 years of age. Conclusions: Having only one ovary visualized on an initial ultrasound
exam considerably hastens complete non-visualization for this population; however, in these women,
ovaries can still be visualized well past menopause, and body habitus is not limiting to TVS ovarian
imaging, thus TVS should be considered capable of capturing an ovarian image in two out of every
three women at 80 years of age.
Keywords: transvaginal ultrasound; ovary; age; BMI; menopausal status; visualization; detection;
body type; weight
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1. Introduction
The first-line imaging approach utilized by radiologists, gynecologists and gynecologic
oncologists for the evaluation of women suspected of having an adnexal mass that could
be an ovarian malignancy is transvaginal ultrasonography (TVS) [1]. TVS requires no
preparation, is well-tolerated, is free of radiation, can be completed quickly and yields highquality detailed images of the pelvis [2], including early malignancies of the uterus [3] and
ovary [4]. TVS has been reported to be significantly more accurate than bimanual clinical
examination in detecting the ovaries, especially since ovaries frequently are not palpable
in women over 55 years of age, or in women weighing more than 200 lbs [5,6]. Although
useful, safe and in wide clinical application, the ultimate limits of modern ultrasonographic
instrumentation to detect human ovaries have not been fully characterized. We have
reported on ovarian size determined by TVS in a large screening population [7,8], and
recently on how age, body habitus and menopausal status affect detectability when both
ovaries are visualized on the first ultrasonography [9]. However, little is known about how
the detectability of the ovaries is influenced by age, body habitus and menopausal status
when only one ovary is visualized on the first ultrasonography. Importantly, the expectation
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that the ovarian structure may or may not be viewable by TVS can directly impact patient
care, especially if imaging is not performed in circumstances when visualization is possible.
For example, if a patient is perceived as too old for the ovaries to be visible by TVS, she may
only receive a bimanual exam. Consequently, the detection of adnexal pathology may be
missed by the physical exam and treatment delayed. However, with an accurate evidencebased perception of the likelihood of ultrasound being able to visualize the ovaries, the
opportunity to receive a timely and safe TVS exam will increase the prospects for a clinical
intervention if needed.
The objective of this study was to understand how age, menopausal status, weight
and BMI influence TVS visualization of the ovaries in women that have only one ovary
present on their initial exam in order to provide accurate expectations for the capability of
TVS to successfully visualize ovarian structure.
2. Materials and Methods
A total of 49,548 women who enrolled in the University of Kentucky Ovarian Cancer
Screening Trial (UKOCST) from January 1987 to November 2021 were evaluated. This prospective cohort trial was approved by the University of Kentucky Institutional Review Board
for Human Studies (IRB# 45030) and is registered at ClinicalTrials.gov: NCT04473833. The
informed consent was approved institutionally and administered by the study sonographers
who were also able to answer questions from participants. Eligibility criteria included (1) all
asymptomatic women aged ≥ 50 years, and (2) asymptomatic women aged ≥ 25 years with a
documented family history of ovarian cancer in at least one primary or secondary relative. All
study participants completed a questionnaire that included medical history, surgical history,
menopausal status, hormonal use and family history of cancer, as previously published [3].
Menopause was defined as the absence of menses for 12 months, as described by the National
Institute of Aging [10]. Women with a known ovarian tumor or a personal history of ovarian
cancer were excluded from the present investigation.
Transvaginal ultrasonography and color Doppler were performed using General
Electric Voluson P5, P8 and P10 units with a 4 to 11 mHz vaginal probe on women with
an empty bladder. In performing the TVS exam, the transducer was gradually inserted
while observing the ultrasound image on a monitor. The urinary bladder was used as a
consistent landmark in the pelvis relative to much more variable positions of the uterus
and the ovaries for assessing the orientation of the transducer. Three scanning approaches
were used to comprehensively assess the pelvis:
(a)
(b)
(c)

Side-to-side movements to achieve sagittal imaging;
90◦ rotation to obtain semi-coronal images and angulation of the probe vertically; and
Varying the depth of probe insertion to expose different pelvic structures within the
field of view. The pelvis was surveyed by slowly sweeping the beam in a sagittal
plane from the midline to the lateral pelvic sidewalls, followed by turning the probe
90 degrees into the coronal plane and sweeping the beam from the cervix to the fundus.
Landmarks for proving structure consisted of identifying the iliac vessels in the pelvic
sidewall and the tubal vessels located posterior and parallel to the fallopian tubes.
Pressure was applied to at least three regions of the abdominal surface to achieve
bowel repositioning in order to assist visualizations. All images were reviewed by a
physician and by at least one of the authors. The study protocol specified that ovaries
be measured in three dimensions. Ovarian volume was calculated using the prolate
ellipsoid formula (length × width × height × 0.523) [11,12]. Thus, a visualization
event was validated by findings that obtained all three measurements. All screening
information was entered into a database (MEDLOG Systems, Crystal Bay, NV, USA)
on a local network. Women who had a normal screen were scheduled to return in
12 months for a repeat screen. Only women with one or more visible ovaries on their
first TVS encounter were utilized in this study and then followed over the course
of annual examinations by TVS. Women who underwent abdominal surgery were
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censored from the present analysis so that surgical interventions did not influence
assessments of visualization outcomes.
Statistical Analyses
Percentages of sonographic findings were determined at the grouping level (i.e., age,
weight, BMI, menopausal status). Years to which visualization was shortened due to only
one ovary visualized on the first exam were determined as the difference in years between
equal percentages of non-visualization on the best-fit curve for both ovaries visualized
on the first visit vs. only one ovary visualized on the first visit. Rates, probability ratio,
Chi-square test of association with Yates and Pearson p-values, Fisher exact probability test,
multiple regression analysis and confidence intervals were obtained using Vassarstat based
on logistic regression [13].
3. Results

•

A total amount of 29,877 women were identified that had both ovaries visualized on their
first TVS exam and were subsequently followed over a course of 202,639 prospective
TVS exams. 9703 women were identified that had only one ovary visualized on their
first TVS exam and were subsequently followed over a course of 63,697 prospective TVS
exams. Demographic characteristics are presented in Table 1.

Table 1. Demographic characteristics of women undergoing TVS. Data represented as mean, median,
(range). Subject data are for the first encounter, while encounter data are across all encounters.

Age (y)
Weight (kg)
Height (cm)
BMI
Pre-menopausal
Peri-menopausal
Post-menopausal

•

All Subjects
(n = 29,877)

All Encounters
(n = 202,639)

55.0, 55 (20–91)
73, 70.3 (38–204)
163.5, 162.6 (119–198)
27.3, 26 (13–80)
5966 (20.9%)
1262 (4.4%)
21,251 (74.6%)

60.1, 60 (20–95)
72.3, 69.4 (36–205)
163.6, 162.6 (119–198)
27, 26 (13–80)
28,618 (14.3%)
5820 (2.9%)
165,390 (82.8%)

Age–non-visualization incidence increased with age (Figure 1A, open red symbols),
while visualization of one ovary decreased with age (Figure 1A, solid blue diamonds).
Despite selection for women with only one ovary visualized on their first visit, both
ovaries were reported about a third of the time subsequently (Figure 1A, solid black
symbols). When the women that had neither ovary visualized on the first ultrasound
exam were examined (n = 7975), a similar fraction was found to have both ovaries
reported as visualized subsequently, indicating that there is variability in the identification of ovarian structures over time. Visualization of one or both ovaries decreased
with age, but one or both ovaries could be visualized in two out of every three women
at 80 years of age and more than 50% of women over 80 years of age (Figure 1A).

Women that had only one ovary visualized on their first visit were characterized by
non-visualization of both ovaries that increased sharply after age 50 (Figure 1A, red line) to
a maximum after age 85 of 47%. A crossover point was noted for women in their mid-80s,
where non-visualization of both ovaries became greater than any visualization (Figure 1A).
The profile for the non-visualization of both ovaries was very well fitted by a 5th degree
polynomial (Figure 1A, gray line, R = 0.997474) over the range 25–90 years of age. The
increase in non-visualizations with age in women that have only one (Figure 1B, open
symbols) or both ovaries (Figure 1B, closed symbols) on the first visit revealed that at each
age more non-visualizations were associated with women that had only one ovary on
their first visit. Using the best-fit curves derived from women that had one (open symbols,
Figure 1C) or both ovaries (solid symbols, Figure 1C) visualized on their first visit, the
separation in time between the equivalent extent of non-visualizations was determined
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(Figure 1C, gray line). Non-visualization was advanced by over 20 years in women under
40 years of age (Figure 1C, gray line) and decreased to over 12 years for women 40–70 years
old, before decreasing to less than 10 years in women over 70 years of age. Across all ages,
4 of 9an average of 9.6 years (SEM = 0.41,
non-visualization of both ovaries was advanced by
median = 9 years, 5–16 years range).

Figure 1. Ovarian visualization relative to age. Panel (A). Sonographic findings visualizing both
ovaries (black line), one ovary (blue line) or neither ovary (red line) when only one ovary was
visualized on the first visit. The line of best fit for visualization of neither ovary is shown in gray
(5th degree polynomial, (R = 0.997474, y = −324.904195 + 31.873955X − 1.205511X2 − 0.021956X3
− 0.000191X4 − 0.00000063935X5 ). Panel (B). An increase in non-visualization of both ovaries as
a function of age was determined when both ovaries were visualized on the first visit (solid red
symbols, R = 0.999619) or when only one ovary was visualized on the first visit (open red symbols).
For when only one ovary was visualized on the first visit, the line of best fit for visualization of neither
ovary is shown in blue (5th degree polynomial, (R = 0.997474, y = −324.904195 + 31.873955X −
1.205511X2 − 0.021956X3 − 0.000191X4 − 0.00000063935X5 ), open symbols), while when both ovaries
were visualized on the first visit, the line of best fit for visualization of neither ovary is shown in blue
(5th degree polynomial, (R = 0.999610, y = −33.913696 + 3.453024X − 0.126511X2 − 0.001996X3 −
0.000012X4 − 0.00000002428358X5 ), solid symbols). Panel (C). Shortening of visualization results
when only one ovary is observed on the first visit. Best fit curves are shown with the gray curve
showing the number of years that non-visualization is advanced when only one ovary is visualized
on the first visit. Where N = number of TVS observations. Age was self-reported and associated with
29,877 women that received 202,639 TVS encounters when both ovaries were visualized on the first
visit and with 9703 women who received 63,697 TVS encounters when only one ovary was visualized
on the first visit. Percentages were determined within each age group.

Figure 1. Ovarian visualization relative to age. Panel (A). Sonographic findings visualizing both
ovaries (black line), one ovary (blue line) or neither ovary (red line) when only one ovary was visualized on the first visit. The line of best fit for visualization of neither ovary is shown in gray (5th
degree polynomial, (R = 0.997474, y = –324.904195+31.873955X–1.205511X2–0.021956X3–0.000191X4–
0.00000063935X5). Panel (B). An increase in non-visualization of both ovaries as a function of age
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Body Habitus–Neither weight (Figure 2A, p > 0.2) nor BMI (Figure 2B, p > 0.12) was
independently associated with ovarian visualization since across all weights and
BMIs, non-visualization of both ovaries was ~20–25%. Both ovaries were visualized in
9
25–30% of women that weighed 180–275 lbs, in 17–23% of6 ofwomen
that weighed over
300 lbs (Figure 2A), and in >25% of women with a BMI over 40 (Figure 2B).

Figure
2. Ovarian
visualization
relative to weight,
BMI and
menopausal
status
when
only one ovarystatus when only one
Figure
2. Ovarian
visualization
relative
to weight,
BMI
and
menopausal
is visualized on the first visit. Panel (A): Weight was reported in 63,244 TVS encounters. Panel (B):
is visualized on the first visit. Panel (A): Weight was reported in 63,244 TVS encounters.
Weight and height were reported for the calculation of BMI in 63,183 TVS encounters. Panel (C):

ovary
Panel
(B): Weight and height were reported for the calculation of BMI in 63,183 TVS encounters. Panel
(C): Menopausal status was self-reported at the time of the TVS exam in 62,297 TVS encounters.
Sonographic findings visualizing both ovaries (black bar), one ovary (blue bar) or neither ovary (red
bar). Differences in the number of TVS exams reflect unreported events (missing data) resulting in
exclusion from analysis. Percentages were determined for each group.

•

Menopausal Status–Menopausal status was self-reported. Non-visualization was ~7%
in pre-menopausal women and ~25% of postmenopausal women (Figure 2C, p < 0.001)
that initially had only one ovary visualized.
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4. Discussion
The visualization of only one ovary on the initial ultrasound exam can hasten nonvisualization of the ovaries by a decade or more. In these women, TVS should be considered
capable of imaging one or both ovaries in two out of every three women at 80 years of
age. Weight, BMI, and menopausal status had little effect on ovarian visualization. The
importance of the present report is that it shows even when only one ovary is visualized
initially, there is considerable opportunity for ovarian visualization.
4.1. Clinical Implications
For women that have only one ovary visualized on their initial ultrasound exam,
TVS imaging should be considered viable even for elderly women and not a reason to
forego TVS. There is the prospect that eventual non-visualization will occur much sooner
in these women, as indicated by the efforts presented here. Nevertheless, age should not
be a factor that deters sonographic exploration of the ovaries. Obesity has become more
prevalent in American women, increasing from 10% in 1979–80 to 40+% in 2013–14 [14].
This increase has been suggested to present a mounting challenge to obtaining high-quality
TVS images of the abdomen [15] because the depth of insonation needed in very large
women attenuates the ultrasound beam. TVS reduces the distance between the vaginal
transducer and pelvic structures, allowing detailed visualization of the ovaries. TVS lacks
ionizing radiation and is not subject to absolute weight/girth restrictions like CT or MRI.
TVS provides an opportunity to bypass the abdominal apron of excess skin and fat that
characterizes obesity. Glanc et al. have reported that there is a paucity of evidence-based
literature on the implications of obesity on TVS [15]. Here, we report that for women having
only one ovary visualized on their first ultrasonography, modern TVS instrumentation can
achieve equivalent ovarian visualization in both obese and non-obese women.
4.2. Research Implications
The results reported here are prospective findings gleaned from long-term data collection in a large ovarian screening study. While it could be possible that newer instrumentation employed over the 30-year course of data collection might influence visualization, there
was only a 2.6% increase in the visualization of both ovaries in the most recent 15 years of
TVS as compared to the first 15 years. This estimate relies on having sufficient numbers in
the groups used to compare effects due to advances in ultrasound technology. Indeed, in
the first 5 years of the screening program, 2068 cases were accrued as compared to 24,808 in
the most recent 15 years. Visualizations of both ovaries were 30.2% less in the first 5 years
than the most recent 15-year experience, indicating that the earliest ultrasound instruments
in this study performed less well. This difference decreased to 0–6% with each 10-year
continuation of the study. However, the bias represented by these early screens is limited
because they account for only 4.2% of the total first screen observations (2068/49,548). Although admission to the study was weighted so that the number of women at least 50 years
of age (86%) was greater than women younger than 50 years of age (14%), a substantial
number of measurements (n = 33,399) were collected for the younger age group. Future
investigation should focus on identifying factors correlated with aging that contribute to
failures to visualize the ovaries, including bladder and bowel dysfunction.
4.3. Strengths and Limitations
The strengths of this paper arise from the large group size of this prospectively studied
cohort of asymptomatic women and from criteria for reporting ovarian visualization
involving measurements in three planes. By concentrating on women that had only one
ovary visualized on their first encounter, this study was able to determine that subsequent
non-visualization comes considerably sooner. It is possible that the group studied varies
from the symptomatic population seen in the clinic, which may affect generalizability;
however, women with abnormal TVS findings are included in this study, as they constitute
a visualization event. Women whose ovaries were removed were excluded; however, any
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bias presented by those that were excluded is small, representing ~5% of the women with
only one ovary visualized on the initial TVS exam. There are factors that can confound the
findings reported here. First, approximately 85% of the participants had their first TVS exam
at age 50–55 years of age, but women younger than this could have had their first exam over
a broader age range (age 25–49). Thus, our use of the first TVS event can create variability
in participants younger than 50 years that is greater than in women older than 50 years of
age. Second, because both ovaries were subsequently visualized after non-visualization
of one or both ovaries in about a third of the TVS studies, clinical interpretations should
realize that non-visualization is not absolute, but subject to the skills of the sonographer
and changes in the physiology of the participant, such as bowel structure and intestinal
gas that obstruct visualization. Third, to compensate for variability, measures have been
presented as percentages in each category under consideration. Although this has resulted
in very high degrees of fit in the curves presented here, it should be kept in mind that the
findings in each category should be recognized as idealized. Taken together, the findings
reported here are most appropriate at the population level.
5. Conclusions
Age has the greatest influence on the visualization of the ovaries. When only one ovary
is visualized on the first ultrasound exam, eventual non-visualization can be advanced by
a decade or more than when both ovaries are confirmed ultrasonographically on the first
exam. Menopause is often perceived as synonymous with aging; however, the ovaries can
be visualized well past the onset of menopause. In a majority of women, the ovaries can be
visualized for 20–25 years beyond menopause, which occurs on average at age 50 [16–18].
Evidence is presented here that the evaluation of the ovarian structure using TVS is possible
at almost any age and weight, and even when only one ovary is visualized initially. Thus,
older and obese patients remain good candidates for TVS exams, providing a solution to
the limitations that occur with physical exams [4,5].
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